US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

BAUSCH + LOMB CORP.

us-stock
To Invest in {{usstockname}}
us-stock
$16.96 -0.0053(-0.53%) BLCO at 04 Dec 2025 04:27 PM Medical Instruments & Supplies
Lowest Today 16.76
Highest Today 17.09
Today’s Open 17.05
Prev. Close 17.05
52 Week High 20.71
52 Week Low 10.45
Day’s Range: Low 16.76 High 17.09
52-Week Range: Low 10.45 High 20.71
1 day return -
1 Week return +4.87
1 month return +13.4
3 month return +16.31
6 month return +47.44
1 year return -13.94
3 year return +11.76
5 year return -
10 year return -

Institutional Holdings

ICAHN CARL C 0.99

Deutsche Bank AG 0.96

Alberta Investment Management Corp 0.92

D. E. Shaw & Co LP 0.74

Goldentree Asset Management LP 0.73

Oaktree Capital Management LLC 0.71

Glenview Capital Management LLC 0.44

Whitebox Advisors, LLC 0.37

Nomura Holdings Inc 0.36

T. Rowe Price Associates, Inc. 0.35

River Road Asset Management, LLC 0.35

Arrowstreet Capital Limited Partnership 0.31

Clearline Capital LP 0.26

Canada Pension Plan Investment Board 0.24

Clark Estates Inc 0.24

UBS Group AG 0.23

Compass Rose Asset Management LP 0.23

FMR Inc 0.22

Allianz Asset Management AG 0.22

T. Rowe Price High Yield Bond 0.17

Fidelity Tactical High Income Sr F8 0.16

T. Rowe Price High Yield 0.16

TANG CAPITAL MANAGEMENT LLC 0.16

T. Rowe Price High Yield Trust - D 0.08

Bestinver Norteamérica FI 0.07

Gabelli Dividend & Income 0.06

Strategic Advisers U.S. Total Stock 0.06

Bestinver Grandes Compañías FI 0.05

Gabelli Health & Wellness 0.05

Fidelity Advisor Multi-Asset Income I 0.05

Ballast SMidCap 0.05

Ballast Small/Mid Cap ETF 0.04

T. Rowe Price Instl High Yield 0.04

JNL Multi-Manager Small Cap Value I 0.04

River Road Small-Mid Cap Value II 0.03

AMG River Road Small-Mid Cap Value N 0.03

Mercer US Small/Mid Cap Equity Y3 0.03

Bestinver Megatendencias FI 0.02

T. Rowe Price Glb High Inc Bd I 0.02

T. Rowe Price Global High Income Bd 0.02

Market Status

Strong Buy: 3

Buy: 3

Hold: 8

Sell: 1

Strong Sell: 0

Fundamentals

Market Cap 6038.94 M

PB Ratio 0.9123

PE Ratio 0.0

Enterprise Value 10546.98 M

Total Assets 13469.00 M

Volume 454777

Company Financials

Annual Revenue FY24:4774000000 4774.0M, FY23:3969000000 3969.0M, FY22:3768000000 3768.0M, FY21:3765000000 3765.0M, FY20:3412000000 3412.0M

Annual Profit FY24:2902000000 2902.0M, FY23:2368000000 2368.0M, FY22:2249000000 2249.0M, FY21:2298000000 2298.0M, FY20:2127000000 2127.0M

Annual Net worth FY24:-317000000 -317.0M, FY23:-207000000 -207.0M, FY22:15000000 15.0M, FY21:182000000 182.0M, FY20:-17000000 -17.0M

Quarterly Revenue Q3/2025:1281000000 1281.0M, Q2/2025:1278000000 1278.0M, Q1/2025:1137000000 1137.0M, Q4/2024:1280000000 1280.0M, Q3/2024:1196000000 1196.0M

Quarterly Profit Q3/2025:771000000 771.0M, Q2/2025:753000000 753.0M, Q1/2025:655000000 655.0M, Q4/2024:779000000 779.0M, Q3/2024:660000000 660.0M

Quarterly Net worth Q3/2025:-28000000 -28.0M, Q2/2025:-62000000 -62.0M, Q1/2025:-212000000 -212.0M, Q4/2024:-3000000 -3.0M, Q3/2024:-124000000 -124.0M

Fund house & investment objective

Company Information Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lenses that are indicated for therapeutic use and provides optical correction during healing. It also offers contact lens care products, eye vitamins, mineral supplements, and over-the-counter eye drops that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. The Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation operates as a subsidiary of Bausch Health Companies Inc.

Organisation Medical Instruments & Supplies

Employees 13500

Industry Medical Instruments & Supplies

CEO Mr. Brenton L. Saunders J.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right